The life sciences industry is undergoing a profound transformation, driven by advancements in digital technologies. In the ASEAN region, this shift is particularly significant as companies strive to enhance efficiency, innovation, and patient outcomes. Our latest research study delves into the current landscape, key drivers, challenges, and future outlook of digital transformation in the life sciences sector in ASEAN.
Key Findings
-
Geographical Focus
The ASEAN region emerged as the top priority for digital transformation with 50% of respondents expressing their focus toward it. Singapore emerges as a key hub for biotech R&D within ASEAN, with 38% of respondents prioritizing it, reflecting the region’s strategic importance.
- Focus Areas
Companies are heavily investing in supply chain management (50%), manufacturing (44%), and marketing (31%). Technologies like RFID and blockchain are enhancing visibility and real-time monitoring in supply chains, while omnichannel marketing is improving engagement with healthcare professionals.
Drivers of Digital Transformation
Looking ahead, several factors are expected to drive digital transformation over the next five years:
• Supply Chain Management: Continues to be a top priority, with 63% of companies seeking to optimize and modernize their supply chains through digital technologies.
• Customer Insights and Business Processes: Improving customer insights and optimizing business processes are critical short-term priorities, expected to be addressed within the next 1-3 years.
• Customer Experience (CX): Enhancing CX will become increasingly important over the next 3-5 years, building on improved supply chains and business processes.
Challenges and Barriers
Despite the promising outlook, several challenges impede the progress of digital transformation. High costs remain a significant barrier, cited by 75% of companies. The lack of adequate training and slow acceptance from regulatory bodies also hinder progress, with 56% of companies recognizing the importance of upskilling employees to ensure successful digital adoption. Organizational factors such as decentralized decision-making, misalignment with business models, and human resistance are other notable barriers.
Technological Adoption
The survey highlighted varying stages of adoption for key technologies. Cloud infrastructure, artificial intelligence, and data lakes are leading in advanced adoption stages, providing secure and cost-effective solutions for managing clinical and genomic data. Most companies are at the beginner or intermediate stages for technologies like IoT, digital twins, and quantum computing.
Future Outlook
As companies look to the next 3-5 years, the integration of digital technologies will continue to open new avenues for efficiency and innovation. In-silico trials, remote patient monitoring, and telehealth are expected to gain prominence, reducing the need for physical visits and enhancing patient care.
The digital transformation in the life sciences sector in ASEAN presents immense opportunities and challenges. By leveraging advanced technologies, addressing barriers, and strategically planning for the future, companies can drive significant improvements in efficiency, innovation, and patient outcomes.
Life Sciences Digital Transformation Research
Download our comprehensive research report to explore detailed insights and practical recommendations on implementing digital transformation in your organization. Stay ahead in the rapidly evolving life sciences landscape.
Using AI to Create an End-to-End Customer Experience
The pharmaceutical industry is at the cusp of a digital revolution, driven by the transformative power of Artificial Intelligence (AI). From drug discovery to manufacturing, AI is making significant inroads into various facets of the industry’s value chain.